Ferring Pharmaceuticals announced strong performance results for 2024, with one part of the announcement standing out as ...

While supply chain interruptions are a strong possibility, the tariffs also provide the industry with a chance to improve ...

The submission is backed by clinical data from over 2,100 patients, including two pivotal Phase III trials in patients ...

As the tariff situation continues to unfold in unexpected ways, the pharma industry must prepare for multiple eventualities. This includes making plans for the most impactful outcomes, which could ...

A new study shows that varenicline combined with brief remote counseling significantly improves vaping abstinence in in patients between 16 and 25 years of age.

CMS’ draft guidance on real-world data study protocols marks a significant move toward transparency and rigor in Medicare ...

Results from the dual Phase III TRIUMpH trials demonstrated the statistical superiority of tegoprazan over lansoprazole in ...

Pooja Lal, VP of strategy and commercial content at Veeva Systems, spoke with Pharmaceutical Executive about some of the ways ...

In the Phase III ARISE trial, Cobenfy administered as an adjunctive treatment to atypical antipsychotics for patients with ...

With combined investments exceeding $53 billion, both companies are deepening their US presence through expanded biologics ...

Chris Springate, CEO, ARC Medical, discusses how postoperative adhesions continue to cause chronic pain, infertility, and life-threatening complications—despite advances in surgical techniques and ...

The simplified requirements for Camzyos are expected to ease prior contraindications, thereby simplifying treatment and ...